• Breast Cancer 840 global 1 0.75 9 0.75 2 0.75 0.75 Roundtable 0 1
  Conceptualizing Guidelines to Manage Patients With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
  Hematology-Oncology2023-03-28 20:00:00
  What do the guidelines say about treating patients with early breast cancer at high risk for recurrence?
  
  0.75ABIM MOC 0.75CME/CE 45MIN

  
  Save
• Breast Cancer 840 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From the Updated Guidelines
  Hematology-Oncology2023-03-26 20:00:00
  Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Inflammatory Bowel Disease 3032545 global 1 1.0 1.0 Clinical Review 0 1
  Northwestern Medicine Presents: The Future of Inflammatory Bowel Disease Management
  Gastroenterology2023-03-22 20:00:00
  Dr. Parambir Dulai discusses new therapies and treatments for IBD, as well as what is on the horizon for IBD patients.
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Breast Cancer 840 global 1 1.0 9 1.0 1.0 Clinical Case 0 1
  Adjuvant Therapy in Hormone Receptor Positive/HER2-Negative Early Breast Cancer: Case Simulations
  Hematology-Oncology2023-03-20 20:00:00
  Do you know the best approaches for identifying and managing high-risk, hormone receptor positive early breast cancer?
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Head and Neck Cancer 3004984 global 1 1.0 9 1.0 2 1.0 1.0 Clinical Review 0 1
  Neuro-Oncology Updates: Insights on the Diagnosis and Management of Low-Grade Glioma, Glioblastoma, and NF1
  Hematology-Oncology2023-03-09 19:00:00
  Did you know that targeted agents and immunotherapies are improving outcomes in patients with low-grade and high-grade brain tumors?
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Melanoma 65 global 1 0.25 9 0.25 0.25 Commentary 0 1
  Depicting LAG3: Exploring a New Target in Metastatic Melanoma
  Hematology-Oncology2023-03-08 19:00:00
  Do you know the role of lymphocytic activation gene 3 (LAG3) in metastatic melanoma and its potential as a treatment target?
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Breast Cancer 840 global 1 0.75 9 0.75 2 0.75 0.75 Roundtable 0 1
  Conceptualizing Guidelines to Manage Patients With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
  Hematology-Oncology2023-03-28 20:00:00
  What do the guidelines say about treating patients with early breast cancer at high risk for recurrence?
  
  0.75ABIM MOC 0.75CME/CE 45MIN

  
  Save
• Breast Cancer 840 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From the Updated Guidelines
  Hematology-Oncology2023-03-26 20:00:00
  Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Inflammatory Bowel Disease 3032545 global 1 1.0 1.0 Clinical Review 0 1
  Northwestern Medicine Presents: The Future of Inflammatory Bowel Disease Management
  Gastroenterology2023-03-22 20:00:00
  Dr. Parambir Dulai discusses new therapies and treatments for IBD, as well as what is on the horizon for IBD patients.
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Breast Cancer 840 global 1 1.0 9 1.0 1.0 Clinical Case 0 1
  Adjuvant Therapy in Hormone Receptor Positive/HER2-Negative Early Breast Cancer: Case Simulations
  Hematology-Oncology2023-03-20 20:00:00
  Do you know the best approaches for identifying and managing high-risk, hormone receptor positive early breast cancer?
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Head and Neck Cancer 3004984 global 1 1.0 9 1.0 2 1.0 1.0 Clinical Review 0 1
  Neuro-Oncology Updates: Insights on the Diagnosis and Management of Low-Grade Glioma, Glioblastoma, and NF1
  Hematology-Oncology2023-03-09 19:00:00
  Did you know that targeted agents and immunotherapies are improving outcomes in patients with low-grade and high-grade brain tumors?
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Melanoma 65 global 1 0.25 9 0.25 0.25 Commentary 0 1
  Depicting LAG3: Exploring a New Target in Metastatic Melanoma
  Hematology-Oncology2023-03-08 19:00:00
  Do you know the role of lymphocytic activation gene 3 (LAG3) in metastatic melanoma and its potential as a treatment target?
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Lung Cancer 5000186 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Community Considerations: Expanding the Utility of Immunotherapy in Patients With Non–Small Cell Lung Cancer
  Hematology-Oncology2023-02-27 19:00:00
  Do you know the latest information on immunotherapy for the management of non-small cell lung cancer (NSCLC)?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Aesthetic Medicine 5000574 global 1 0.5 2 0.5 0.5 Roundtable 0 1
  The Complete Guide to Chemical Peels: Why, What, and How?
  General Surgery2023-02-26 19:00:00
  Chemical peeling can yield great results in skin rejuvenation; our experts explain what you need to know to start peeling in your own practice.
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Biologic Therapy 5000033 global 1 0.25 9 0.25 0.25 Clinical Review 0 1
  What's Your Take? Perspectives on Immunotherapy for Early-Stage Solid Tumors
  Hematology-Oncology2023-02-22 19:00:00
  Did you know? Immunotherapy is now being used for the neoadjuvant and adjuvant treatment of solid tumors -- find out more here!
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Glioblastoma 1541 global 1 0.25 9 0.25 0.25 Clinical Review 0 1
  Case in Point: An Expert's Approach to Caring for Patients With Glioblastoma
  Hematology-Oncology2023-02-21 19:00:00
  A 65-year-old patient, John, presents with rapid, progressive left-sided weakness. You suspect glioblastoma. What would you do next?
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Thromboembolism 63912 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Evaluating Evolving Approaches to Treating Thrombosis in Cancer: From Concept to Clinic
  Hematology-Oncology2023-02-08 19:00:00
  Confront the challenges of treating cancer-associated thromboembolism (CAT): learn about the utility of factor XI, current and emerging data, and implications for improved patient care.
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Breast Cancer 840 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding the Data and Their Implications
  Hematology-Oncology2023-01-29 19:00:00
  Will the newly reported monarchE data change your clinical practice for patients with HR+/HER- early breast cancer?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Thromboembolism 63912 global 1 0.25 9 0.25 0.25 Commentary 0 1
  From Inpatient to Outpatient: Integrating VTE Prevention Strategies Across the Care Continuum
  Cardiology2023-01-19 19:00:00
  Learn more about venous thromboembolism (VTE) prevention strategies as patients transition to the post-hospital setting.
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Melanoma 65 global 1 0.25 9 0.25 0.25 Clinical Review 0 1
  Assess Your Understanding of Immune Checkpoint Inhibitors in Metastatic Melanoma
  Hematology-Oncology2023-01-12 19:00:00
  Did you know that melanoma has more somatic mutations than any other cancer type?
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Heart Failure (HF) 64646 global 1 2.5 9 2.5 2 2.5 2.5 Roundtable 0 1
  Heart Failure and Myocardial Disease
  Cardiology2023-01-03 19:00:00
  There are so many new options for the treatment of heart failure. Are you up to date?
  
  2.5ABIM MOC 2.5CME/CE 150MIN

  
  Save
• 0 global 1 1.0 9 1.0 3 1.0 1.0 Clinical Case 0 1
  CMV in the Transplant Patient: A Virtual Patient Simulation Focused on Individualized Care
  Infectious Diseases2023-01-03 19:00:00
  Are you current on CMV management in the transplant patient?
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Cardiac Surgery 6005128 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Acute Kidney Injury After Cardiac Surgery: Expert Insights on Current Understanding   
  Nephrology2023-01-03 19:00:00
  Acute kidney injury after cardiac surgery is common but potentially reversible. Listen as our experts discuss strategies to prevent and mitigate risk.
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Cardiovascular Risk Management 3029460 global 1 2.5 9 2.5 2 2.5 2.5 Roundtable 0 1
  Cardioprevention, CV Risk Reduction, and Cardiometabolic Updates
  Cardiology2022-12-29 19:00:00
  A multi-targeted and interprofessional approach to lower the risk of CV events.
  
  2.5ABIM MOC 2.5CME/CE 150MIN

  
  Save

Education For Your Patient

• Click here for access to online educational resources to share with your patients and their care partners

Policies and Requirements

• CME Policies
• State CME Requirements